Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease
Clinical trial NCT03318523 · TERMINATED
Trial details
- NCT number
- NCT03318523
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-10
- Primary completion
- 2020-10-26
- Enrollment
- 357
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.